Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

1.

Anticancer activity of pristimerin in epidermal growth factor receptor 2-positive SKBR3 human breast cancer cells.

Lee JS, Yoon IS, Lee MS, Cha EY, Thuong PT, Diep TT, Kim JR.

Biol Pharm Bull. 2013;36(2):316-25.

PMID:
23370361
[PubMed - indexed for MEDLINE]
Free Article
3.

Ursolic acid, a naturally occurring triterpenoid, suppresses migration and invasion of human breast cancer cells by modulating c-Jun N-terminal kinase, Akt and mammalian target of rapamycin signaling.

Yeh CT, Wu CH, Yen GC.

Mol Nutr Food Res. 2010 Sep;54(9):1285-95. doi: 10.1002/mnfr.200900414. Erratum in: Mol Nutr Food Res.2010 Nov;54(11):1696.

PMID:
20352621
[PubMed - indexed for MEDLINE]
4.

Anticancer properties of pomolic acid-induced AMP-activated protein kinase activation in MCF7 human breast cancer cells.

Youn SH, Lee JS, Lee MS, Cha EY, Thuong PT, Kim JR, Chang ES.

Biol Pharm Bull. 2012;35(1):105-10.

PMID:
22223345
[PubMed - indexed for MEDLINE]
Free Article
5.

Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells.

Jin Q, Yuan LX, Boulbes D, Baek JM, Wang YN, Gomez-Cabello D, Hawke DH, Yeung SC, Lee MH, Hortobagyi GN, Hung MC, Esteva FJ.

Breast Cancer Res. 2010;12(6):R96. doi: 10.1186/bcr2777. Epub 2010 Nov 16.

PMID:
21080941
[PubMed - indexed for MEDLINE]
Free PMC Article
6.
7.

Fatty acid synthase inhibition by amentoflavone suppresses HER2/neu (erbB2) oncogene in SKBR3 human breast cancer cells.

Lee JS, Sul JY, Park JB, Lee MS, Cha EY, Song IS, Kim JR, Chang ES.

Phytother Res. 2013 May;27(5):713-20. doi: 10.1002/ptr.4778. Epub 2012 Jul 5.

PMID:
22767439
[PubMed - indexed for MEDLINE]
8.
9.

A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines.

Puig T, Aguilar H, Cufí S, Oliveras G, Turrado C, Ortega-Gutiérrez S, Benhamú B, López-Rodríguez ML, Urruticoechea A, Colomer R.

Breast Cancer Res. 2011;13(6):R131. doi: 10.1186/bcr3077. Epub 2011 Dec 16.

PMID:
22177475
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Platycodin D induces apoptosis in MCF-7 human breast cancer cells.

Yu JS, Kim AK.

J Med Food. 2010 Apr;13(2):298-305. doi: 10.1089/jmf.2009.1226.

PMID:
20412017
[PubMed - indexed for MEDLINE]
12.
13.

Low-scale phosphoproteome analyses identify the mTOR effector p70 S6 kinase 1 as a specific biomarker of the dual-HER1/HER2 tyrosine kinase inhibitor lapatinib (Tykerb) in human breast carcinoma cells.

Vazquez-Martin A, Oliveras-Ferraros C, Colomer R, Brunet J, Menendez JA.

Ann Oncol. 2008 Jun;19(6):1097-109. doi: 10.1093/annonc/mdm589. Epub 2008 Feb 17.

PMID:
18283037
[PubMed - indexed for MEDLINE]
Free Article
14.

Antitumor efficacy of piperine in the treatment of human HER2-overexpressing breast cancer cells.

Do MT, Kim HG, Choi JH, Khanal T, Park BH, Tran TP, Jeong TC, Jeong HG.

Food Chem. 2013 Dec 1;141(3):2591-9. doi: 10.1016/j.foodchem.2013.04.125. Epub 2013 May 24.

PMID:
23870999
[PubMed - indexed for MEDLINE]
15.

23,24-Dihydrocucurbitacin B induces G2/M cell-cycle arrest and mitochondria-dependent apoptosis in human breast cancer cells (Bcap37).

Yang L, Wu S, Zhang Q, Liu F, Wu P.

Cancer Lett. 2007 Oct 28;256(2):267-78. Epub 2007 Aug 6.

PMID:
17681423
[PubMed - indexed for MEDLINE]
16.

Up-regulation of acetyl-CoA carboxylase alpha and fatty acid synthase by human epidermal growth factor receptor 2 at the translational level in breast cancer cells.

Yoon S, Lee MY, Park SW, Moon JS, Koh YK, Ahn YH, Park BW, Kim KS.

J Biol Chem. 2007 Sep 7;282(36):26122-31. Epub 2007 Jul 13.

PMID:
17631500
[PubMed - indexed for MEDLINE]
Free Article
17.
18.

A novel semisynthetic inhibitor of the FRB domain of mammalian target of rapamycin blocks proliferation and triggers apoptosis in chemoresistant prostate cancer cells.

Morad SA, Schmid M, Büchele B, Siehl HU, El Gafaary M, Lunov O, Syrovets T, Simmet T.

Mol Pharmacol. 2013 Feb;83(2):531-41. doi: 10.1124/mol.112.081349. Epub 2012 Dec 3.

PMID:
23208958
[PubMed - indexed for MEDLINE]
Free Article
19.

Breast cancer expressing the activated HER2/neu is sensitive to gefitinib in vitro and in vivo and acquires resistance through a novel point mutation in the HER2/neu.

Piechocki MP, Yoo GH, Dibbley SK, Lonardo F.

Cancer Res. 2007 Jul 15;67(14):6825-43.

PMID:
17638894
[PubMed - indexed for MEDLINE]
Free Article
20.

Reactive oxygen species-dependent activation of Bax and poly(ADP-ribose) polymerase-1 is required for mitochondrial cell death induced by triterpenoid pristimerin in human cervical cancer cells.

Byun JY, Kim MJ, Eum DY, Yoon CH, Seo WD, Park KH, Hyun JW, Lee YS, Lee JS, Yoon MY, Lee SJ.

Mol Pharmacol. 2009 Oct;76(4):734-44. doi: 10.1124/mol.109.056259. Epub 2009 Jul 2.

PMID:
19574249
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk